Min Fu

1.2k total citations
32 papers, 799 citations indexed

About

Min Fu is a scholar working on Cardiology and Cardiovascular Medicine, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Min Fu has authored 32 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Hepatology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Min Fu's work include Hepatitis C virus research (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Min Fu is often cited by papers focused on Hepatitis C virus research (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Min Fu collaborates with scholars based in United States, China and United Kingdom. Min Fu's co-authors include Barry Greenberg, John G.F. Cleland, Faı̈ez Zannad, Mandeep R. Mehra, William M. Byra, Stefan D. Anker, Dirk J. van Veldhuisen, Theodore E. Spiro, Mihai Gheorghiade and Christopher C. Nessel and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Min Fu

28 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Min Fu United States	14	369	138	98	87	81	32	799
Steven D. Salhanick United States	13	173 0.5×	83 0.6×	70 0.7×	77 0.9×	75 0.9×	23	694
Laura T. Grip United States	12	465 1.3×	64 0.5×	25 0.3×	132 1.5×	18 0.2×	18	727
G. Inselmann Germany	14	269 0.7×	208 1.5×	29 0.3×	25 0.3×	93 1.1×	32	760
Kazuhito Shiosakai Japan	15	151 0.4×	88 0.6×	12 0.1×	44 0.5×	65 0.8×	58	544
Siv Jönsson Sweden	18	89 0.2×	64 0.5×	9 0.1×	58 0.7×	21 0.3×	50	901
A M H P van den Besselaar Netherlands	18	431 1.2×	80 0.6×	28 0.3×	271 3.1×	45 0.6×	53	865
Jeffrey W. Dubb United States	11	93 0.3×	43 0.3×	12 0.1×	26 0.3×	147 1.8×	17	626
Fethullah Gerin Türkiye	9	178 0.5×	129 0.9×	5 0.1×	41 0.5×	51 0.6×	15	608
Isabelle Antony France	18	953 2.6×	153 1.1×	25 0.3×	5 0.1×	164 2.0×	39	1.5k
Jaspal Gujral United States	7	63 0.2×	101 0.7×	140 1.4×	17 0.2×	28 0.3×	15	623

Countries citing papers authored by Min Fu

Since Specialization

Citations

This map shows the geographic impact of Min Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Fu more than expected).

Fields of papers citing papers by Min Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Fu. The network helps show where Min Fu may publish in the future.

Co-authorship network of co-authors of Min Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Min Fu. A scholar is included among the top collaborators of Min Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Fu. Min Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jie, Rong Ren, Min Fu, et al.. (2025). Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): A bibliometric study. Pharmacological Research - Modern Chinese Medicine. 14. 100585–100585.

Fu, Min, Hui Liu, Wenbo Yang, et al.. (2024). Virtual Cold Chain Method with Comprehensive Evaluation to Reveal the Effects of Temperature Abuse on Blueberry Quality. Foods. 13(23). 3731–3731. 1 indexed citations

Lin, Tingting, Min Fu, Li Wang, et al.. (2024). Bleeding complications related to external ventricular drainage placement in patients with ruptured intracranial aneurysms: a single-center study. Frontiers in Surgery. 11. 1403668–1403668.

Zhao, Junjie, Zhaoming Wang, Chenyu Tian, et al.. (2023). Single-cell RNA sequencing reveals the lineage of malignant epithelial cells and upregulation of TAGLN2 promotes peritoneal metastasis in gastric cancer. Clinical & Translational Oncology. 25(12). 3405–3419. 7 indexed citations

Fu, Min, Qian Zhang, Hui Chen, et al.. (2023). [Clinicopathological and molecular diagnostic features of early-onset gastric cancer: a study based on data from a single-center dedicated gastric cancer database].. PubMed. 26(10). 963–967.

Sun, Xiaomao, Wei Yuan, Min Fu, et al.. (2020). [Clinicopathological features and prognosis of 59 patients with platelet-derived growth factor α-mutant gastrointestinal stromal tumor].. PubMed. 23(9). 880–887. 2 indexed citations

Shu, Peng, Xiaomao Sun, Yong Fang, et al.. (2020). Clinical outcomes of different therapeutic modalities for rectal gastrointestinal stromal tumor: Summary of 14-year clinical experience in a single center. International Journal of Surgery. 77. 1–7. 17 indexed citations

Greenberg, Barry, Stefan D. Anker, William M. Byra, et al.. (2018). Effects of Rivaroxaban on Thrombotic Events in Heart Failure Patients With Coronary Disease and Sinus Rhythm. Circulation. 138(25). 1 indexed citations

Zannad, Faı̈ez, Barry Greenberg, John G.F. Cleland, et al.. (2015). Rationale and Design of a Randomized, Double-Blind, Event-Driven, Multicentre Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Exacerbation of Heart Failure: The COMMANDER HF Trial. European Journal of Heart Failure. 17(7). 735–742. 60 indexed citations

10.

Scott, Jane, Kathleen Rosa, Min Fu, et al.. (2014). Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection. BMC Infectious Diseases. 14(1). 465–465. 16 indexed citations

11.

Rosa, Kathleen, Min Fu, Leen Gilles, et al.. (2014). Validation of the Fatigue Severity Scale in chronic hepatitis C. Health and Quality of Life Outcomes. 12(1). 90–90. 30 indexed citations

12.

Reddy, K. Rajender, Stefan Zeuzem, Fabien Zoulim, et al.. (2014). Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial. The Lancet Infectious Diseases. 15(1). 27–35. 44 indexed citations

13.

Scott, Jane, Min Fu, Elaine Brohan, et al.. (2014). Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies. Journal of Viral Hepatitis. 22(8). 639–650. 12 indexed citations

14.

Scott, Jane, Kathleen Rosa, Min Fu, et al.. (2013). Fatigue Severity Scale: Reliability, Validity And Interpretation Of Change -- Evidence From Two Clinical Trials In Patients With Chronic Hcv Infection. Value in Health. 16(3). A216–A216. 3 indexed citations

15.

Scott, Jane, Min Fu, Elaine Brohan, et al.. (2013). Patients with Chronic Hepatitis C Virus Treated with Simeprevir Added to Peginterferon and Ribavirin Experienced Less Time with Fatigue, Depressive Symptoms, and Functional Limitations: Results from Patients in the Quest-1, Quest-2, and Promise Studies. Value in Health. 16(7). A362–A362. 3 indexed citations

16.

Dong, Gaogao, Lixin Tian, Ruijin Du, Min Fu, & H. Eugene Stanley. (2013). Analysis of percolation behaviors of clustered networks with partial support–dependence relations. Physica A Statistical Mechanics and its Applications. 394. 370–378. 25 indexed citations

17.

Cao, Xia, Min Fu, Liang Wang, et al.. (2012). Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles. Acta Biomaterialia. 8(6). 2104–2112. 32 indexed citations

18.

Tong, Shanshan, Ying Xu, Li Wang, et al.. (2011). Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo. Acta Pharmacologica Sinica. 32(7). 973–980. 89 indexed citations

19.

Pérgola, Pablo E., Gary Gartenberg, Min Fu, et al.. (2010). A Randomized Controlled Study Comparing Once-Weekly to Every-2-Week and Every-4-Week Dosing of Epoetin Alfa in CKD Patients with Anemia. Clinical Journal of the American Society of Nephrology. 5(4). 598–606. 9 indexed citations

20.

Fu, Min, et al.. (2001). Efficacy of Nonprescription Doses of Ibuprofen for Treating Migraine Headache. A Randomized Controlled Trial. Headache The Journal of Head and Face Pain. 41(7). 665–679. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact